Simultaneous separation and determination of 16 testosterone and nandrolone esters in equine plasma using ultra high performance liquid chromatography-tandem mass spectrometry for doping control

Journal of Chromatography A

Volumn 1218, Issue 26, 2011, Pages 3982-3993

  You, Youwen ^a   Uboh, Cornelius E ^a,b   Soma, Lawrence R ^a   Guan, Fuyu ^a   Li, Xiaoqing ^a   Liu, Ying ^a   Rudy, Jeffrey A ^b   Chen, Jinwen ^a   Tsang, Deborah ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WEST CHESTER UNIVERSITY   (United States)

Author keywords

Doping control; Equine plasma; LC MS MS; Nandrolone esters; Testosterone esters

Indexed keywords

DOPING CONTROL; EQUINE PLASMA; LC-MS/MS; NANDROLONE; TESTOSTERONE ESTER;

AMMONIUM COMPOUNDS; CHROMATOGRAPHY; DEUTERIUM; ELECTROSPRAY IONIZATION; ESTERIFICATION; ESTERS; ETHERS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETERS; MASS SPECTROMETRY; METHANOL; PLASMAS; SOLVENT EXTRACTION;

LIQUIDS;

ESTER DERIVATIVE; NANDROLONE ACETATE; NANDROLONE CYPIONATE; NANDROLONE DECANOATE; NANDROLONE ESTER DERIVATIVE; NANDROLONE LAURATE; NANDROLONE PHENPROPIONATE; NANDROLONE UNDECANOATE; TESTOSTERONE ACETATE; TESTOSTERONE CAPROATE; TESTOSTERONE CIPIONATE; TESTOSTERONE DECANOATE; TESTOSTERONE ENANTATE; TESTOSTERONE ESTER; TESTOSTERONE ISOCAPROATE; TESTOSTERONE LAURATE; TESTOSTERONE PHENYLPROPIONATE; TESTOSTERONE PROPIONATE; TESTOSTERONE UNDECANOATE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; CONTROLLED STUDY; DOPING; HIGH THROUGHPUT SCREENING; HORSE; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID LIQUID EXTRACTION; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEPARATION TECHNIQUE; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPING IN SPORTS; DRUG STABILITY; FORMIC ACIDS; HORSES; METHANOL; NANDROLONE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; TESTOSTERONE;

CONGIOPODIDAE; EQUIDAE;

EID: 79957855739     PISSN: 00219673     EISSN: 18733778     Source Type: Journal    
DOI: 10.1016/j.chroma.2011.04.087     Document Type: Article

References (31)

1. You Y.W., Uboh C.E., Soma L.R., Guna F.Y., Li X.Q., Rudy J.A., Liu Y., Chen J.W. Rapid Commun. Mass Spectrom. 2009, 23:2035.
2. Liu Y., Uboh C.E., Soma L.R., Li X.Q., Guan F., You Y., Rudy J.A., Chen J.W. Drug Test. Anal. 2011, 3:56.
3. Guan F., Uboh C.E., Soma L.R., You Y., Liu Y., Li X.Q. J. Mass Spectrom. 2010, 45:1270.
4. Cox J.E., Williams J.H., Rowe P.H., Smith J.A. Equine Vet. J. 1973, 5(1973):85.
5. Ganjam V.K., Kenney R.M. J. Reprod. Fertil. 1975, Suppl. 23:67.
6. L.R. Soma, C.E. Uboh, Y. You, F. Guan, D. Tsang, S. McDonnell, J. Vet. Pharmacol. Ther., 34 (2011), doi:10.1111/j.1365-288.2011.01295.x.
7. World Anti-Doping Agency: The World Anti-Doping Code. The 2008 prohibited list. International Standard. Available from: (accessed 25.01.11). http://www.wada-ama.org/rtecontent/document/2008_List_en.pdf.
8. Kickman A.T., Brooks R.V., Collyer S.C., Cowan D.A., Nanjee M.N., Southan G.J., Wheeler M.J. Br. J. Sports Med. 1990, 24:253.
9. Carlström K., Palonek E., Garle M., Oftebro H., Stanghelle J., Björkhem I. Clin. Chem. 1992, 38:1779.
10. Piper T., Mareck U., Geyer H., Flenker U., Thevis M., Platen P., Schänzer W. Rapid Commun. Mass Spectrom. 2008, 22:2161.
11. Aguilera R., Chapman T.E., Starcevic B., Hatton C.K., Catlin D.H. Clin. Chem. 2001, 47:292.
12. Ueki M., Okano M. Rapid Commun. Mass Spectrom. 1999, 13:2237.
13. Yamada M., Kinoshita K., Kurosawa M., Saito K., Nakazawa H. J. Pharmaceut. Biomed. Anal. 2007, 45:654.
14. Larner J.M., Pahuja S.L., Shackleton C.H., McMurray W.J., Giordano G., Hochberg R.B. J. Biol. Chem. 1993, 268:13893.
15. Borg W., Shackleton C.H.L., Pahuja S.L., Hochberg R.B. Proc. Natl. Acad. Sci. 1995, 92:1545.
16. Höld K., Borges C.R., Wilkins D.G., Rollins D.E., Joseph R.E. J. Anal. Toxicol. 1999, 23:416.
17. Peng S.H., Segura J., Farré M., González J.C., Torre X.D.L. Steroids 2001, 67:39.
18. Boyer S., Garcia P., Popot M.A., Steiner V., Lesieur M. J. Chromatogr. B 2007, 852:684.
19. Segura J., Pichini S., Peng S.H., Torre X.D.L. Forensic Sci. Int. 2000, 107:347.
20. Gaillard Y., Vayssette F., Balland A., Pépin G. J. Chromatogr. B 1999, 735:189.
21. de la Torre X., Segura J., Polettini A., Montagna M. J. Mass Spectrom. 1995, 30:1393.
22. Shackleton C.H.L., Chuang H., Kim J., de la Torre X., Segura J. Steroids 1997, 625:523.
23. U.S. Food and Drug Administration. Guidance for industry-Bioanalytical method validation. Available from: (accessed 14.04.10). http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070107.pdf.
24. Guan F.Y., Uboh C.E., Soma L.R., Luo Y., Rudy J., Tobin T. J. Chromatogr. B 2005, 829:56.
25. PoP E., Oniciu D., Pape M.E., Cramer C.T., Dasseux J.H. Croat. Chem. Acta 2004, 77:301.
26. Guan F.Y., Soma L.R., Luo Y., Uboh C.E.S. J. Am. Soc. Mass Spectrom. 2006, 17:477.
27. Williams T.M., Kind A.J., Houghton E., Hill D.W. J. Mass Spectrom. 1999, 34:206.
28. Nielen M.W.F., Lasaroms J.J.P., Mulder P.P.J., Hende J.V., van Rhijn J.A., Groot M.J. J. Chromatogr. B 2006, 830:126.
29. Shackleton C.H.L., Chuang H., Kim J., de la Torre X., Segura J. Steroids 1997, 62:523.
30. Soma L.R., Uboh C.E., Guan F., Mcdonnell S. J. Vet. Pharmacol. Ther. 2008, 6:587.
31. Bethem R., Boison J., Gale J., Heller D., Lehotay S., Loo J., Musser S., Price P., Stein S. J. Am. Soc. Mass Spectrom. 2003, 14:528.